Copertina

Response to comment on “Restrospective cohort study of ambulatory care pharmacist interventions' impact on incidence of therapeutic response in anxiety and depression”

Fuente: Wiley Open Access

Salvato in:

Dettagli Bibliografici
Autori principali:	Ashlyn M. Kiebach, Tara E. McAlpine, Mitchell H. Cavanaugh, Jessica A. Benzer
Natura:	Artículo Open Access
Pubblicazione:	Wiley 2025
Soggetti:	JACCP: JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY
Accesso online:	Acceder al recurso
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!

Documenti analoghi

Retrospective cohort study of ambulatory care pharmacist interventions’ impact on incidence of therapeutic response in anxiety and depression
di: Ashlyn M. Kiebach, et al.
Pubblicazione: (2024)

Comment on “Retrospective cohort study of ambulatory care pharmacist interventions' impact on incidence of therapeutic response in anxiety and depression”
di: Angeleki Zecopoulos, et al.
Pubblicazione: (2025)

Impact of a Pharmacy Intern‐Led Electronic Health Record Outreach Program on Vaccine Uptake in a Primary Care Network
di: Alexis A. Anthony, et al.
Pubblicazione: (2025)

A call to action for ambulatory care pharmacists for the treatment of depression and anxiety in primary care: An opinion paper of the ambulatory care and central nervous system practice research networks of the American College of Clinical Pharmacy
di: Richard J. Silvia, et al.
Pubblicazione: (2025)

National survey of transplant pharmacist ambulatory care practices
di: Helen Sweiss, et al.
Pubblicazione: (2024)

Unique model for pharmacist cross‐coverage in the ambulatory care setting
di: Anna Abrahamson, et al.
Pubblicazione: (2024)

Comparison of patients achieving treatment success with a glucagon‐like peptide‐1 receptor agonist for weight management between primary care provider and pharmacist co‐managed patients
di: Jacob Johnson, et al.
Pubblicazione: (2025)

The economic impact of the pharmacist in heart failure ambulatory care clinics: A scoping review
di: Justine Brasseur‐Masse, et al.
Pubblicazione: (2025)

The effect of chronic care management on diabetes‐related outcomes in interprofessional care of a medically complex patient population
di: Ashlyn Aguiniga, et al.
Pubblicazione: (2024)

Age‐based transitions of care: Where is the pharmacist?
di: Sara W. Hovey, et al.
Pubblicazione: (2024)

Long‐term effect of pharmacist‐led interventions on diabetes distress
di: Shae L. Martel, et al.
Pubblicazione: (2025)

Identifying factors that influence the selection of a postgraduate year 2 ambulatory care residency program
di: Alexandra K. Statczar, et al.
Pubblicazione: (2024)

Nationwide evaluation of the clinical impact of acute care adult medicine pharmacists
di: Jennifer A. Szwak, et al.
Pubblicazione: (2024)

Insights on antifungal therapeutic drug monitoring from infectious diseases physicians and hospital‐based pharmacists: A focus group analysis
di: Annie Cheung, et al.
Pubblicazione: (2025)

Using a rule‐based decision tool for medication dose selection to improve patient safety and the need for pharmacist intervention
di: Tyler Finocchio, et al.
Pubblicazione: (2024)

An analysis of the impact on total cost of care within a pharmacist‐led comprehensive medication management program
di: Julie Anne Earby, et al.
Pubblicazione: (2024)

Evaluating the impact of pharmacist counseling on patient satisfaction and willingness to pay: A study in the Pakistan health care context
di: Asma Ghulam Mustafa, et al.
Pubblicazione: (2024)

Integrating clinical pharmacists into transitions of care: A qualitative study of barriers and facilitators among federally qualified health centers
di: Ben C. D. Weideman, et al.
Pubblicazione: (2024)

Implementation of a pharmacist‐driven chronic obstructive pulmonary disease transitions of care service at a large academic medical center
di: Maggie M. Lycouras, et al.
Pubblicazione: (2024)

Impact of internal medicine pharmacists on antimicrobial stewardship
di: Ashley Rizzo, et al.
Pubblicazione: (2024)

Differences in the approach to guideline‐directed medical therapy in patients with heart failure with reduced ejection fraction: A survey of cardiologists, internists, and pharmacists
di: Lana Alhashimi, et al.
Pubblicazione: (2024)

Comparison of community pharmacy‐measured blood pressure and ambulatory blood pressure monitoring: A pilot study
di: Christine Tran, et al.
Pubblicazione: (2024)

Identification of education gaps for pharmacists treating transgender and gender‐diverse patients: A quality initiative at a single academic health system
di: Kellyn Engstrom, et al.
Pubblicazione: (2025)

Professional and career development needs of clinical pharmacists in settings outside academia
di: Sarah M. Hayes, et al.
Pubblicazione: (2024)

Trends and considerations for interprofessional continuing education activities for pharmacists and pharmacy technicians
di: Logan T. Murry, et al.
Pubblicazione: (2025)

Evaluation of oral targeted anticancer drug interactions and their management by oncology pharmacists
di: Sarah L. Wede, et al.
Pubblicazione: (2024)

Consensus recommendations for the integration of critical care pharmacists on intensive care unit teams: Endorsed by the American Association of Critical‐Care Nurses, American College of Clinical Pharmacy, American Society of Health‐System Pharmacists, Institute for Safe Medication Practices, and Society of Critical Care Medicine
di: Andrea Sikora, et al.
Pubblicazione: (2025)

Development and application of a toolkit for community pharmacist‐led review of patients with diabetes
di: Justine Borg, et al.
Pubblicazione: (2025)

Empowering pharmacists with data: Steps toward proactive medication safety and quality improvement
di: Lara K. Ellinger, et al.
Pubblicazione: (2024)

Evaluation of a psychiatric pharmacist consultation service in a multispecialty outpatient clinic
di: Deni Hui, et al.
Pubblicazione: (2024)

Identifying ideal pharmacist‐to‐patient ratios for the successful provision of clinical pharmacy services
di: Jay L. Martello, et al.
Pubblicazione: (2024)

Comment on “Professional and career development needs of clinical pharmacists in settings outside academia”
di: G. Christina Gutierrez, et al.
Pubblicazione: (2024)

Reply to comment on “Insights into clinical pharmacy practice in Latin America”
di: Esteban Zavaleta‐Monestel, et al.
Pubblicazione: (2024)

HIV pre‐exposure prophylaxis champion preceptorship training for pharmacists and nurses in the United States
di: Parya Saberi, et al.
Pubblicazione: (2024)

Remediation strategies for student pharmacists with socio‐behavioral issues in the experiential curriculum: A case series
di: Lindsey Dayer, et al.
Pubblicazione: (2024)

Impact of interprofessional and simulation activities on student pharmacists' professional identity formation: A qualitative study
di: Christina H. Sherrill, et al.
Pubblicazione: (2025)

Impact of pharmacist management on chronic obstructive pulmonary disease in a family medicine residency clinic
di: Jacqueline Elaine Figueras, et al.
Pubblicazione: (2025)

Evaluating practitioner attitudes toward pharmacist clinician prescribing of buprenorphine for the treatment of opioid use disorder
di: Miguel Lopez, et al.
Pubblicazione: (2025)

Pharmacist certification of drug therapy modification: A survey of pharmacist‐reported practices, facilitators, and barriers in Georgia
di: Rebecca H. Stone, et al.
Pubblicazione: (2024)

State of the union: A review of state‐based laws and regulations supporting pharmacist payment for clinical services
Pubblicazione: (2024)